C. Chiang

发表

Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer

Brian J. Stevenson, D. Torigian, H. Nisenbaum, 2018, Science Translational Medicine.

Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?

L. Kandalaft, C. Chiang, Michele Graciotti, 2018, Vaccines.

Are dendritic cells the most appropriate therapeutic vaccine for patients with ovarian cancer?

L. Kandalaft, C. Chiang, Michele Graciotti, 2020, Current opinion in biotechnology.

Adjuvants for Enhancing the Immunogenicity of Whole Tumor Cell Vaccines

G. Coukos, L. Kandalaft, C. Chiang, 2011, International reviews of immunology.

Potential approaches for more successful dendritic cell-based immunotherapy

G. Coukos, L. Kandalaft, C. Chiang, 2015, Expert opinion on biological therapy.

Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytes

P. Gimotty, G. Coukos, A. Facciabene, 2020, Journal for ImmunoTherapy of Cancer.

Day-4 Myeloid Dendritic Cells Pulsed with Whole Tumor Lysate Are Highly Immunogenic and Elicit Potent Anti-Tumor Responses

G. Coukos, B. Czerniecki, D. Powell, 2011, PloS one.

Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate

G. Coukos, B. Czerniecki, B. Levine, 2011, Journal of Translational Medicine.

The differential influence of allogeneic tumor cell death via DNA damage on dendritic cell maturation and antigen presentation.

B. Chain, S. Sohaib, D. Katz, 2003, Cancer research.

Hypochlorous Acid: A Natural Adjuvant That Facilitates Antigen Processing, Cross-Priming, and the Induction of Adaptive Immunity

B. Chain, M. Nowakowska, D. Katz, 2009, The Journal of Immunology.

Adaptive Immunity Cross-Priming, and the Induction of That Facilitates Antigen Processing, Hypochlorous Acid: A Natural Adjuvant

M. Nowakowska, D. Katz, C. Chiang, 2009 .

Assessing the potential of hypochlorous acid-oxidised allogenic tumour cells as a source of antigen for dendritic cell-based immunotherapy of ovarian carcinoma

C. Chiang, 2008 .

Cryoablation and Immunotherapy: An Enthralling Synergy to Confront the Tumors

R. Duran, A. Denys, L. Kandalaft, 2019, Front. Immunol..

Integrating Cancer Vaccines in the Standard-of-Care of Ovarian Cancer: Translating Preclinical Models to Human

L. Kandalaft, C. Chiang, A. Sarivalasis, 2021, Cancers.

In vivo cancer vaccination: Which dendritic cells to target and how?

L. Kandalaft, C. Chiang, 2018, Cancer treatment reviews.

Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer

Brian J. Stevenson, D. Torigian, H. Nisenbaum, 2021, npj Vaccines.

The current clinical landscape of personalized cancer vaccines.

L. Kandalaft, C. Chiang, Raphaël Rovelli, 2022, Cancer treatment reviews.

Whole tumor antigen vaccines.

G. Coukos, C. Chiang, F. Benencia, 2010, Seminars in immunology.

Whole Tumor Antigen Vaccines: Where Are We?

G. Coukos, L. Kandalaft, C. Chiang, 2015, Vaccines.

A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer

G. Coukos, J. Tanyi, R. Mick, 2013, Journal of Translational Medicine.

Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer

Drew A. Torigian, Lana E. Kandalaft, George Coukos, 2013, Oncoimmunology.

Oxidation of Ovarian Epithelial Cancer Cells by Hypochlorous Acid Enhances Immunogenicity and Stimulates T Cells that Recognize Autologous Primary Tumor

J. Ledermann, E. Benjamin, B. Chain, 2008, Clinical Cancer Research.

Rate of Freeze Impacts the Survival and Immune Responses Post Cryoablation of Melanoma

C. Sempoux, R. Duran, A. Denys, 2021, Frontiers in Immunology.

A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside

Drew A. Torigian, Lana E. Kandalaft, George Coukos, 2013, Clinical Cancer Research.

Autologous whole-tumor antigen vaccination in combination with adoptive T cell therapy for patients with recurrent ovarian cancer

G. Coukos, D. Powell, J. Tanyi, 2013, Journal of Immunotherapy for Cancer.

Abstract LB-335: Autologous whole-tumor antigen vaccination in combination with adoptive T cell therapy for patients with recurrent ovarian cancer.

G. Coukos, D. Powell, J. Tanyi, 2013 .

Hypochlorous acid enhances immunogenicity and uptake of allogeneic ovarian tumor cells by dendritic cells to cross-prime tumor-specific T cells

J. Ledermann, B. Chain, D. Katz, 2006, Cancer Immunology, Immunotherapy.

A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer

G. Coukos, J. Tanyi, R. Mick, 2013, Journal of Translational Medicine.

A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside.

D. Torigian, H. Nisenbaum, G. Coukos, 2013, Clinical cancer research : an official journal of the American Association for Cancer Research.

A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside

D. Torigian, H. Nisenbaum, G. Coukos, 2013, Clinical Cancer Research.